Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7326 p748
20 November 2004

This article
Reprint   Photocopy

PDF 100K, Acrobat Reader

Letters

· New contract (12)
· Apothecaries
· Overseas members
· Preoperative association
· Boots the Chemists
· Levothyroxine
· Complementary medicine
· Retention fee
· Preregistration exam


Letters to the Editor

Levothyroxine

Do not suspend levothyroxine

Professor J. H. Perrin, MRPharmS

I have read Kenneth Bird’s letter (PJ, 6 November, p680) on his problems with an extemporaneous “suspension” of levothyroxine, using Keltrol, a polysaccharide gum, giving a neutral solution in water. Using only the information given in the package insert, Martindale and the Merck Index it should be obvious not to try to suspend this drug because of the low dose, and its relative ease of oxidation. In addition, levothyroxine has a significant solubility in water.

In the reported case what happened to the drug is not obvious but the low dose would make it especially difficult to obtain uniform quantities of drug per unit volume. Some or all of the drug may have gone into solution and some may have become oxidised during preparation and subsequent shaking of the “suspension”. Was the drug protected from light and refrigerated? Refrigeration causes solubility and particle size changes, contributing further to the dangers of this formulation. There are other possibilities involving the gum. Did the drug bind to the gum, and as a result was not available for absorption? Or did this potential binding accelerate the oxidation of the drug, so rendering it inactive?

The correct way to give a fraction of a tablet, other than half a tablet, is to grind the tablet and weigh out the appropriate amount. Of course some oxidation is possible during this process and only a few doses should be prepared at a time. The powder so produced should be “hidden” in jelly or ice cream immediately before dosing. It can also be mixed with water immediately before administration via a dropper.

Reading Martindale and speaking with our drug information service (University of Florida) tells me that the younger the infant the higher the dose per kilogram becomes. Commercially available doses or half tablets are usually prescribed. There is a research paper1 stating that levothyroxine is stable for eight days when protected from light at 4C in a 40 per cent aqueous glycerol solution. Again, Martindale informs us that the drug is more soluble in ethanol than water, hence triturating the tablet with the glycerol before adding the water would be the best method of effecting solution. Again some oxidation (discoloration) is possible. Centrifugation would be better than filtration if clarification is deemed necessary.

J. H. Perrin
Gainesville, Florida

Reference

1. Boulton DW, Fawcett JP, Woods DJ. Stability of an extemporaneously compounded levothyroxine sodium oral liquid. American Journal of Health-System Pharmacists 1996;53:1157–6115.

Send your letter to The Editor

Previous Topic (Boots the Chemists)
Next Topic (Complementary medicine)

Back to Top


©The Pharmaceutical Journal